Donald Trump's solution to soaring American drug prices is to have other countries, such as Canada, raise their prices. This is not a new position; American officials have been advocating this approach for at least the past ...
May 18, 2018
1
1
Drug shortages and price hikes have become a critical issue in the health care industry. A recent example of this occurred when a shortage of intravenous fluids and injectable opioids ensued due to manufacturing delays in ...
Aug 9, 2018
0
0
Italian pharmaceutical Leadiant has been fined almost 20 million euros for allegedly overcharging for medicine used to treat a rare cholesterol disease, the Dutch consumer watchdog said on Monday.
Jul 19, 2021
0
1
Georgia State Law associate professor Yaniv Heled focuses his career on the intersection of biotechnology and the law. For nearly a decade, he has dedicated much of his research to the regulation of bio-pharmaceuticals (also ...
Mar 26, 2020
0
0
Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring.
Jun 17, 2019
0
0
When drug manufacturers raise the list price for brand-name prescription drugs, do patients' out-of-pocket costs rise too? A new study published in JAMA Network Open by Dr. Benjamin Rome and colleagues in the Brigham's Division ...
May 4, 2021
0
0
About one in 10 prescription drugs—mainly brand-name and expensive drugs and those for rare diseases—has a manufacturer-sponsored patient support program, which usually includes financial, nursing and educational supports.
Nov 27, 2023
0
0
In Switzerland and other European countries, drug prices are regulated to ensure affordable access to drugs. In the last few years, many European countries have introduced rebate schemes for drugs. In most cases, however, ...
Feb 17, 2021
0
3
UK policymakers preparing trade deals post-Brexit can learn important lessons from New Zealand's 'unique drug agency' the Pharmaceutical Management Agency (PHARMAC), if prices for therapies and access to key drugs are to ...
Jul 19, 2021
0
1
Connecticut's attorney general and 45 of his colleagues are seeking to expand a federal antitrust lawsuit against generic drugmakers to include more manufacturers and medications, as well as senior executives at two companies.
Oct 31, 2017
1
0
